Search research articles
Contact Us
Filters
Showing results (151-160 of 213) with videos related to
Page
of 22
Sort By:
Journal of Clinical and Experimental Hepatology
|
November 7, 2022
Corrigendum to "Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients with Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken" [J Clin Exp Hepatol 12 (2022) 841-852]
Vaneet Jearth, Prachi S Patil, Shaesta Mehta, et al.
World Journal of Surgical Oncology
|
February 5, 2013
D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy
Shailesh V Shrikhande, Savio G Barreto, Sanjay D Talole, et al.
Langenbeck'S Archives of Surgery
|
July 9, 2011
Superior mesenteric artery first combined with uncinate process approach versus uncinate process first approach in pancreatoduodenectomy: a comparative study evaluating perioperative outcomes
Shailesh V Shrikhande, Savio George Barreto, Yashodhan D Bodhankar, et al.
Medical Oncology (Northwood, London, England)
|
March 23, 2018
Gemcitabine-cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward
Vikas Ostwal, Rohit Swami, Shraddha Patkar, et al.
Journal of Gastrointestinal Cancer
|
May 24, 2016
Second-Line Palliative Chemotherapy in Advanced Gall Bladder Cancer, CAP-IRI: Safe and Effective Option
Anant Ramaswamy, Vikas Ostwal, Nikhil Pande, et al.
Journal of Global Oncology
|
September 23, 2018
Financial Impact of Complex Cancer Surgery in India: A Study of Pancreatic Cancer
Guruchanna Basavaiah, Priyanka D Rent, Eugene G Rent, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
May 1, 2018
Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications
Vikram A Chaudhari, Vikas Ostwal, Shraddha Patkar, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
April 7, 2026
Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer
Shraddha Patkar, Tanvi M Shah, Mufaddal Kazi, et al.
Surgical Oncology
|
April 29, 2026
Navigating early recurrences in post-hepatectomy hepatocellular carcinoma: Preventive strategies and prognostic indicators
Mizelle D'Silva, Gurudutt Varty, Shraddha Patkar, et al.
Journal of Gastrointestinal Oncology
|
March 11, 2017
High dose chemoradiation for unresectable hilar cholangiocarcinomas using intensity modulated external beam radiotherapy: a single tertiary care centre experience
Reena Engineer, Shaesta Mehta, Nikhil Kalyani, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 213) with videos related to
Sort By:
Page
of 22
Journal of Clinical and Experimental Hepatology
|
November 7, 2022
Corrigendum to "Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients with Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken" [J Clin Exp Hepatol 12 (2022) 841-852]
Vaneet Jearth, Prachi S Patil, Shaesta Mehta, et al.
World Journal of Surgical Oncology
|
February 5, 2013
D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy
Shailesh V Shrikhande, Savio G Barreto, Sanjay D Talole, et al.
Langenbeck'S Archives of Surgery
|
July 9, 2011
Superior mesenteric artery first combined with uncinate process approach versus uncinate process first approach in pancreatoduodenectomy: a comparative study evaluating perioperative outcomes
Shailesh V Shrikhande, Savio George Barreto, Yashodhan D Bodhankar, et al.
Medical Oncology (Northwood, London, England)
|
March 23, 2018
Gemcitabine-cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward
Vikas Ostwal, Rohit Swami, Shraddha Patkar, et al.
Journal of Gastrointestinal Cancer
|
May 24, 2016
Second-Line Palliative Chemotherapy in Advanced Gall Bladder Cancer, CAP-IRI: Safe and Effective Option
Anant Ramaswamy, Vikas Ostwal, Nikhil Pande, et al.
Journal of Global Oncology
|
September 23, 2018
Financial Impact of Complex Cancer Surgery in India: A Study of Pancreatic Cancer
Guruchanna Basavaiah, Priyanka D Rent, Eugene G Rent, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
May 1, 2018
Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications
Vikram A Chaudhari, Vikas Ostwal, Shraddha Patkar, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
April 7, 2026
Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer
Shraddha Patkar, Tanvi M Shah, Mufaddal Kazi, et al.
Surgical Oncology
|
April 29, 2026
Navigating early recurrences in post-hepatectomy hepatocellular carcinoma: Preventive strategies and prognostic indicators
Mizelle D'Silva, Gurudutt Varty, Shraddha Patkar, et al.
Journal of Gastrointestinal Oncology
|
March 11, 2017
High dose chemoradiation for unresectable hilar cholangiocarcinomas using intensity modulated external beam radiotherapy: a single tertiary care centre experience
Reena Engineer, Shaesta Mehta, Nikhil Kalyani, et al.
Page
of 22